25 XP   0   0   10

Vitrolife AB
Buy, Hold or Sell?

Let's analyse Vitrolife together

PenkeI guess you are interested in Vitrolife AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Vitrolife AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Vitrolife AB

I send you an email if I find something interesting about Vitrolife AB.

Quick analysis of Vitrolife (30 sec.)










What can you expect buying and holding a share of Vitrolife? (30 sec.)

How much money do you get?

How much money do you get?
kr0.31
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
kr93.93
Expected worth in 1 year
kr-24.70
How sure are you?
90.0%

+ What do you gain per year?

Total Gains per Share
kr-115.23
Return On Investment
-69.6%

For what price can you sell your share?

Current Price per Share
kr165.60
Expected price per share
kr155.20 - kr191.80
How sure are you?
50%

1. Valuation of Vitrolife (5 min.)




Live pricePrice per Share (EOD)

kr165.60

Intrinsic Value Per Share

kr31.65 - kr64.83

Total Value Per Share

kr125.59 - kr158.76

2. Growth of Vitrolife (5 min.)




Is Vitrolife growing?

Current yearPrevious yearGrowGrow %
How rich?$1.1b$1.5b-$369.9m-31.6%

How much money is Vitrolife making?

Current yearPrevious yearGrowGrow %
Making money-$354.6m$36.2m-$390.9m-110.2%
Net Profit Margin-109.7%12.2%--

How much money comes from the company's main activities?

3. Financial Health of Vitrolife (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#31 / 332

Most Revenue
#85 / 332

Most Profit
#323 / 332

Most Efficient
#244 / 332

What can you expect buying and holding a share of Vitrolife? (5 min.)

Welcome investor! Vitrolife's management wants to use your money to grow the business. In return you get a share of Vitrolife.

What can you expect buying and holding a share of Vitrolife?

First you should know what it really means to hold a share of Vitrolife. And how you can make/lose money.

Speculation

The Price per Share of Vitrolife is kr165.60. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Vitrolife.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Vitrolife, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr93.93. Based on the TTM, the Book Value Change Per Share is kr-29.66 per quarter. Based on the YOY, the Book Value Change Per Share is kr10.33 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.85 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Vitrolife.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-2.62-1.6%-2.62-1.6%0.270.2%-0.33-0.2%-0.09-0.1%
Usd Book Value Change Per Share-2.73-1.6%-2.73-1.6%0.950.6%1.530.9%0.840.5%
Usd Dividend Per Share0.080.0%0.080.0%0.070.0%0.070.0%0.050.0%
Usd Total Gains Per Share-2.65-1.6%-2.65-1.6%1.030.6%1.591.0%0.890.5%
Usd Price Per Share17.93-17.93-17.15-24.94-27.31-
Price to Earnings Ratio-6.85--6.85-64.01-90.28-153.09-
Price-to-Total Gains Ratio-6.76--6.76-16.71-35.71-106.29-
Price to Book Ratio2.07-2.07-1.51-7.58-24.95-
Price-to-Total Gains Ratio-6.76--6.76-16.71-35.71-106.29-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share15.25176
Number of shares65
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.080.07
Usd Book Value Change Per Share-2.731.53
Usd Total Gains Per Share-2.651.59
Gains per Quarter (65 shares)-172.46103.61
Gains per Year (65 shares)-689.84414.43
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
120-710-70017397404
241-1420-139035794818
361-2131-20805211911232
481-2841-27707015881646
5102-3551-34608719852060
6122-4261-415010523822474
7142-4971-484012227792888
8163-5681-553014031763302
9183-6392-622015735733716
10203-7102-691017539704130

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%21.01.02.087.5%
Book Value Change Per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%21.03.00.087.5%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%15.00.09.062.5%
Total Gains per Share0.01.00.00.0%2.01.00.066.7%4.01.00.080.0%9.01.00.090.0%21.03.00.087.5%

Fundamentals of Vitrolife

About Vitrolife AB

Vitrolife AB (publ) provides assisted reproduction products. It also offers sperm processing, oocyte retrieval needles, micromanipulation pipettes, time-lapse systems, and evaluation tools, laser and imaging systems, IVF media and oil, embryo transfer, cryopreservation, and genomics kits. In addition, the company offers EmbryoScope and time-lapse systems; time-lapse dishes; and evaluation tools for time-lapse systems. The company operates in Europe, the Middle East, India and Africa; Asia; Japan and Pacific; Americas; and Asia. Vitrolife AB (publ) was founded in 1994 and is based in Gothenburg, Sweden.

Fundamental data was last updated by Penke on 2024-04-25 19:30:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating efficient.
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is fair priced.

1.1. Profitability of Vitrolife AB.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Vitrolife earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Vitrolife to the Medical Devices industry mean.
  • A Net Profit Margin of -109.7% means that kr-1.10 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Vitrolife AB:

  • The MRQ is -109.7%. The company is making a huge loss. -2
  • The TTM is -109.7%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-109.7%TTM-109.7%0.0%
TTM-109.7%YOY12.2%-121.8%
TTM-109.7%5Y-5.7%-104.0%
5Y-5.7%10Y9.3%-14.9%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-109.7%-11.2%-98.5%
TTM-109.7%-20.4%-89.3%
YOY12.2%-13.3%+25.5%
5Y-5.7%-20.4%+14.7%
10Y9.3%-24.9%+34.2%
1.1.2. Return on Assets

Shows how efficient Vitrolife is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Vitrolife to the Medical Devices industry mean.
  • -23.5% Return on Assets means that Vitrolife generated kr-0.23 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Vitrolife AB:

  • The MRQ is -23.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -23.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-23.5%TTM-23.5%0.0%
TTM-23.5%YOY1.9%-25.4%
TTM-23.5%5Y2.1%-25.6%
5Y2.1%10Y9.1%-7.0%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-23.5%-4.0%-19.5%
TTM-23.5%-4.6%-18.9%
YOY1.9%-4.2%+6.1%
5Y2.1%-3.8%+5.9%
10Y9.1%-4.8%+13.9%
1.1.3. Return on Equity

Shows how efficient Vitrolife is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Vitrolife to the Medical Devices industry mean.
  • -30.3% Return on Equity means Vitrolife generated kr-0.30 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Vitrolife AB:

  • The MRQ is -30.3%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -30.3%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-30.3%TTM-30.3%0.0%
TTM-30.3%YOY2.4%-32.6%
TTM-30.3%5Y2.0%-32.3%
5Y2.0%10Y10.8%-8.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-30.3%-4.1%-26.2%
TTM-30.3%-5.6%-24.7%
YOY2.4%-5.3%+7.7%
5Y2.0%-6.1%+8.1%
10Y10.8%-6.7%+17.5%

1.2. Operating Efficiency of Vitrolife AB.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Vitrolife is operating .

  • Measures how much profit Vitrolife makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Vitrolife to the Medical Devices industry mean.
  • An Operating Margin of 20.9% means the company generated kr0.21  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Vitrolife AB:

  • The MRQ is 20.9%. The company is operating efficient. +1
  • The TTM is 20.9%. The company is operating efficient. +1
Trends
Current periodCompared to+/- 
MRQ20.9%TTM20.9%0.0%
TTM20.9%YOY20.2%+0.6%
TTM20.9%5Y25.9%-5.1%
5Y25.9%10Y28.3%-2.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ20.9%-24.1%+45.0%
TTM20.9%-16.4%+37.3%
YOY20.2%-13.4%+33.6%
5Y25.9%-19.9%+45.8%
10Y28.3%-25.0%+53.3%
1.2.2. Operating Ratio

Measures how efficient Vitrolife is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 0.79 means that the operating costs are kr0.79 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Vitrolife AB:

  • The MRQ is 0.791. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.791. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.791TTM0.7910.000
TTM0.791YOY0.804-0.012
TTM0.7915Y0.742+0.049
5Y0.74210Y0.720+0.022
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7911.428-0.637
TTM0.7911.424-0.633
YOY0.8041.396-0.592
5Y0.7421.416-0.674
10Y0.7201.375-0.655

1.3. Liquidity of Vitrolife AB.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Vitrolife is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 3.44 means the company has kr3.44 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Vitrolife AB:

  • The MRQ is 3.436. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.436. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.436TTM3.4360.000
TTM3.436YOY2.531+0.905
TTM3.4365Y4.223-0.787
5Y4.22310Y4.004+0.219
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.4362.685+0.751
TTM3.4362.697+0.739
YOY2.5313.466-0.935
5Y4.2233.629+0.594
10Y4.0043.507+0.497
1.3.2. Quick Ratio

Measures if Vitrolife is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Vitrolife to the Medical Devices industry mean.
  • A Quick Ratio of 2.59 means the company can pay off kr2.59 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Vitrolife AB:

  • The MRQ is 2.592. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 2.592. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ2.592TTM2.5920.000
TTM2.592YOY1.804+0.789
TTM2.5925Y3.395-0.802
5Y3.39510Y3.117+0.278
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ2.5921.521+1.071
TTM2.5921.666+0.926
YOY1.8042.142-0.338
5Y3.3952.316+1.079
10Y3.1172.416+0.701

1.4. Solvency of Vitrolife AB.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Vitrolife assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Vitrolife to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.22 means that Vitrolife assets are financed with 22.4% credit (debt) and the remaining percentage (100% - 22.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Vitrolife AB:

  • The MRQ is 0.224. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.224. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.224TTM0.2240.000
TTM0.224YOY0.185+0.038
TTM0.2245Y0.181+0.043
5Y0.18110Y0.182-0.001
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2240.402-0.178
TTM0.2240.390-0.166
YOY0.1850.343-0.158
5Y0.1810.442-0.261
10Y0.1820.460-0.278
1.4.2. Debt to Equity Ratio

Measures if Vitrolife is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Vitrolife to the Medical Devices industry mean.
  • A Debt to Equity ratio of 28.8% means that company has kr0.29 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Vitrolife AB:

  • The MRQ is 0.288. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.288. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.288TTM0.2880.000
TTM0.288YOY0.228+0.061
TTM0.2885Y0.223+0.065
5Y0.22310Y0.227-0.004
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2880.589-0.301
TTM0.2880.573-0.285
YOY0.2280.492-0.264
5Y0.2230.624-0.401
10Y0.2270.700-0.473

2. Market Valuation of Vitrolife AB

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Vitrolife generates.

  • Above 15 is considered overpriced but always compare Vitrolife to the Medical Devices industry mean.
  • A PE ratio of -6.85 means the investor is paying kr-6.85 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Vitrolife AB:

  • The EOD is -5.824. Based on the earnings, the company is expensive. -2
  • The MRQ is -6.848. Based on the earnings, the company is expensive. -2
  • The TTM is -6.848. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.824MRQ-6.848+1.024
MRQ-6.848TTM-6.8480.000
TTM-6.848YOY64.011-70.859
TTM-6.8485Y90.280-97.128
5Y90.28010Y153.090-62.810
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-5.824-0.984-4.840
MRQ-6.848-1.709-5.139
TTM-6.848-2.190-4.658
YOY64.011-2.629+66.640
5Y90.280-2.300+92.580
10Y153.090-1.789+154.879
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Vitrolife AB:

  • The EOD is 35.212. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 41.400. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 41.400. Based on how much money comes from the company's main activities, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD35.212MRQ41.400-6.188
MRQ41.400TTM41.4000.000
TTM41.400YOY45.938-4.539
TTM41.4005Y98.380-56.980
5Y98.38010Y159.517-61.137
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD35.212-0.986+36.198
MRQ41.400-1.578+42.978
TTM41.400-2.973+44.373
YOY45.938-6.238+52.176
5Y98.380-4.850+103.230
10Y159.517-5.292+164.809
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Vitrolife is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 2.07 means the investor is paying kr2.07 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Vitrolife AB:

  • The EOD is 1.763. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.073. Based on the equity, the company is underpriced. +1
  • The TTM is 2.073. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.763MRQ2.073-0.310
MRQ2.073TTM2.0730.000
TTM2.073YOY1.507+0.566
TTM2.0735Y7.579-5.507
5Y7.57910Y24.950-17.371
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD1.7631.954-0.191
MRQ2.0732.376-0.303
TTM2.0732.468-0.395
YOY1.5073.169-1.662
5Y7.5793.906+3.673
10Y24.9504.273+20.677
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Vitrolife AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---29.657-29.6570%10.330-387%16.577-279%9.155-424%
Book Value Per Share--93.93393.9330%123.591-24%71.790+31%39.803+136%
Current Ratio--3.4363.4360%2.531+36%4.223-19%4.004-14%
Debt To Asset Ratio--0.2240.2240%0.185+21%0.181+24%0.182+23%
Debt To Equity Ratio--0.2880.2880%0.228+27%0.223+29%0.227+27%
Dividend Per Share--0.8490.8490%0.812+5%0.729+16%0.544+56%
Eps---28.432-28.4320%2.909-1077%-3.612-87%-1.027-96%
Free Cash Flow Per Share--4.7034.7030%4.053+16%3.205+47%2.301+104%
Free Cash Flow To Equity Per Share--2.4882.4880%-0.244+110%10.194-76%5.554-55%
Gross Profit Margin--1.1781.1780%-0.528+145%0.328+259%0.279+322%
Intrinsic Value_10Y_max--64.829--------
Intrinsic Value_10Y_min--31.654--------
Intrinsic Value_1Y_max--4.321--------
Intrinsic Value_1Y_min--2.546--------
Intrinsic Value_3Y_max--14.641--------
Intrinsic Value_3Y_min--8.238--------
Intrinsic Value_5Y_max--26.959--------
Intrinsic Value_5Y_min--14.530--------
Market Cap22430024524.800-18%26371532457.60026371532457.6000%25220232889.600+5%36684467646.720-28%40169519162.560-34%
Net Profit Margin---1.097-1.0970%0.122-1000%-0.057-95%0.093-1283%
Operating Margin--0.2090.2090%0.202+3%0.259-20%0.283-26%
Operating Ratio--0.7910.7910%0.804-2%0.742+7%0.720+10%
Pb Ratio1.763-18%2.0732.0730%1.507+38%7.579-73%24.950-92%
Pe Ratio-5.824+15%-6.848-6.8480%64.011-111%90.280-108%153.090-104%
Price Per Share165.600-18%194.700194.7000%186.200+5%270.840-28%296.570-34%
Price To Free Cash Flow Ratio35.212-18%41.40041.4000%45.938-10%98.380-58%159.517-74%
Price To Total Gains Ratio-5.748+15%-6.758-6.7580%16.712-140%35.710-119%106.290-106%
Quick Ratio--2.5922.5920%1.804+44%3.395-24%3.117-17%
Return On Assets---0.235-0.2350%0.019-1325%0.021-1217%0.091-358%
Return On Equity---0.303-0.3030%0.024-1386%0.020-1629%0.108-380%
Total Gains Per Share---28.808-28.8080%11.142-359%17.307-266%9.700-397%
Usd Book Value--1171788300.0001171788300.0000%1541754000.000-24%895552991.040+31%496523073.000+136%
Usd Book Value Change Per Share---2.731-2.7310%0.951-387%1.527-279%0.843-424%
Usd Book Value Per Share--8.6518.6510%11.383-24%6.612+31%3.666+136%
Usd Dividend Per Share--0.0780.0780%0.075+5%0.067+16%0.050+56%
Usd Eps---2.619-2.6190%0.268-1077%-0.333-87%-0.095-96%
Usd Free Cash Flow--58667700.00058667700.0000%50562900.000+16%39979744.260+47%28704346.500+104%
Usd Free Cash Flow Per Share--0.4330.4330%0.373+16%0.295+47%0.212+104%
Usd Free Cash Flow To Equity Per Share--0.2290.2290%-0.022+110%0.939-76%0.512-55%
Usd Market Cap2065805258.734-18%2428818139.3452428818139.3450%2322783449.132+5%3378639470.263-28%3699612714.872-34%
Usd Price Per Share15.252-18%17.93217.9320%17.149+5%24.944-28%27.314-34%
Usd Profit---354677100.000-354677100.0000%36287400.000-1077%-45062135.400-87%-12808448.310-96%
Usd Revenue--323455200.000323455200.0000%297851400.000+9%205429197.360+57%142193751.810+127%
Usd Total Gains Per Share---2.653-2.6530%1.026-359%1.594-266%0.893-397%
 EOD+4 -4MRQTTM+0 -0YOY+18 -185Y+14 -2210Y+14 -22

3.2. Fundamental Score

Let's check the fundamental score of Vitrolife AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-5.824
Price to Book Ratio (EOD)Between0-11.763
Net Profit Margin (MRQ)Greater than0-1.097
Operating Margin (MRQ)Greater than00.209
Quick Ratio (MRQ)Greater than12.592
Current Ratio (MRQ)Greater than13.436
Debt to Asset Ratio (MRQ)Less than10.224
Debt to Equity Ratio (MRQ)Less than10.288
Return on Equity (MRQ)Greater than0.15-0.303
Return on Assets (MRQ)Greater than0.05-0.235
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Vitrolife AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.388
Ma 20Greater thanMa 50175.795
Ma 50Greater thanMa 100185.444
Ma 100Greater thanMa 200184.280
OpenGreater thanClose165.300
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2019-12-312020-12-312021-12-312022-12-312023-12-31
Retained Earnings  1,216,423277,4691,493,892236,0951,729,987270,0132,000,000-3,993,000-1,993,000
Income before Tax  492,694-126,503366,19193,778459,96977,031537,000-4,249,000-3,712,000
Net Income  382,785-95,940286,84554,155341,00053,000394,000-4,245,000-3,851,000



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in SEK. All numbers in thousands.

Summary
Total Assets16,391,000
Total Liabilities3,668,000
Total Stockholder Equity12,722,000
 As reported
Total Liabilities 3,668,000
Total Stockholder Equity+ 12,722,000
Total Assets = 16,391,000

Assets

Total Assets16,391,000
Total Current Assets1,914,000
Long-term Assets14,477,000
Total Current Assets
Cash And Cash Equivalents 861,000
Net Receivables 583,000
Inventory 413,000
Other Current Assets 57,000
Total Current Assets  (as reported)1,914,000
Total Current Assets  (calculated)1,914,000
+/-0
Long-term Assets
Property Plant Equipment 349,000
Goodwill 9,591,000
Intangible Assets 4,312,000
Long-term Assets Other 2,000
Long-term Assets  (as reported)14,477,000
Long-term Assets  (calculated)14,254,000
+/- 223,000

Liabilities & Shareholders' Equity

Total Current Liabilities557,000
Long-term Liabilities3,111,000
Total Stockholder Equity12,722,000
Total Current Liabilities
Short-term Debt 147,000
Short Long Term Debt 114,000
Accounts payable 171,000
Other Current Liabilities 187,000
Total Current Liabilities  (as reported)557,000
Total Current Liabilities  (calculated)619,000
+/- 62,000
Long-term Liabilities
Long term Debt 1,875,000
Capital Lease Obligations 100,000
Long-term Liabilities  (as reported)3,111,000
Long-term Liabilities  (calculated)1,975,000
+/- 1,136,000
Total Stockholder Equity
Common Stock28,000
Retained Earnings -1,993,000
Accumulated Other Comprehensive Income 1,144,000
Other Stockholders Equity 13,543,000
Total Stockholder Equity (as reported)12,722,000
Total Stockholder Equity (calculated)12,722,000
+/-0
Other
Capital Stock28,000
Cash and Short Term Investments 861,000
Common Stock Shares Outstanding 135,395
Current Deferred Revenue52,000
Liabilities and Stockholders Equity 16,391,000
Net Debt 1,228,000
Net Invested Capital 14,711,000
Net Working Capital 1,357,000
Property Plant and Equipment Gross 784,000
Short Long Term Debt Total 2,089,000



Balance Sheet

Currency in SEK. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-31
> Total Assets 
173,216
328,042
188,515
183,995
185,538
211,370
271,034
299,460
342,662
359,315
429,388
466,780
462,198
487,808
972,482
1,059,243
1,250,491
1,422,424
1,697,467
2,138,687
2,305,089
19,428,796
20,551,000
16,391,000
16,391,00020,551,00019,428,7962,305,0892,138,6871,697,4671,422,4241,250,4911,059,243972,482487,808462,198466,780429,388359,315342,662299,460271,034211,370185,538183,995188,515328,042173,216
   > Total Current Assets 
0
0
79,533
88,010
83,083
91,886
75,087
91,875
105,162
103,818
131,563
153,436
142,816
187,325
308,782
414,454
476,519
709,905
850,576
1,150,224
1,414,442
1,406,601
1,572,000
1,914,000
1,914,0001,572,0001,406,6011,414,4421,150,224850,576709,905476,519414,454308,782187,325142,816153,436131,563103,818105,16291,87575,08791,88683,08388,01079,53300
       Cash And Cash Equivalents 
11,620
62,097
36,376
51,549
44,935
48,295
14,470
18,505
14,009
15,987
18,617
20,873
11,680
53,769
107,598
199,572
189,245
395,963
490,810
689,538
973,566
630,094
578,000
861,000
861,000578,000630,094973,566689,538490,810395,963189,245199,572107,59853,76911,68020,87318,61715,98714,00918,50514,47048,29544,93551,54936,37662,09711,620
       Short-term Investments 
49,305
73,771
0
0
19,935
0
0
183
180
147
111
295
289
120
17
842
0
0
-1
0
0
0
0
0
00000-100842171202892951111471801830019,9350073,77149,305
       Net Receivables 
19,386
24,601
23,055
13,424
13,742
17,199
29,067
29,776
38,655
38,768
42,830
57,291
58,361
67,275
102,166
104,045
133,514
153,614
189,231
240,179
236,848
463,614
542,000
583,000
583,000542,000463,614236,848240,179189,231153,614133,514104,045102,16667,27558,36157,29142,83038,76838,65529,77629,06717,19913,74213,42423,05524,60119,386
       Other Current Assets 
2,122
2,399
50,504
52,428
2,548
1,590
3,222
3,192
44,933
45,984
56,336
66,854
68,727
73,640
109,508
112,598
141,620
163,386
198,580
11,687
1
-1
47,000
57,000
57,00047,000-1111,687198,580163,386141,620112,598109,50873,64068,72766,85456,33645,98444,9333,1923,2221,5902,54852,42850,5042,3992,122
   > Long-term Assets 
0
0
108,982
95,985
102,455
119,484
195,947
207,585
237,500
255,497
297,825
313,344
319,382
300,483
663,700
644,789
773,972
712,519
846,891
988,463
890,648
18,022,195
18,978,000
14,477,000
14,477,00018,978,00018,022,195890,648988,463846,891712,519773,972644,789663,700300,483319,382313,344297,825255,497237,500207,585195,947119,484102,45595,985108,98200
       Property Plant Equipment 
43,168
106,370
21,676
19,154
18,373
88,802
81,736
76,639
94,802
93,038
91,316
95,444
94,445
85,956
92,322
89,641
93,655
84,432
94,126
173,359
142,113
332,974
318,000
349,000
349,000318,000332,974142,113173,35994,12684,43293,65589,64192,32285,95694,44595,44491,31693,03894,80276,63981,73688,80218,37319,15421,676106,37043,168
       Goodwill 
23,722
22,001
4,741
4,011
3,282
4,011
83,265
83,265
88,250
97,301
120,289
120,771
182,114
183,275
364,545
350,474
403,216
408,937
421,610
425,841
403,239
12,994,620
13,874,000
9,591,000
9,591,00013,874,00012,994,620403,239425,841421,610408,937403,216350,474364,545183,275182,114120,771120,28997,30188,25083,26583,2654,0113,2824,0114,74122,00123,722
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
5,442
9,986
9,666
8,948
9,168
23,602
32,674
0
0
0
0
000032,67423,6029,1688,9489,6669,9865,4420000000000000
       Intangible Assets 
25,685
26,010
7,841
6,480
6,563
3,794
24,682
24,030
96,924
105,176
65,323
131,461
33,892
22,982
196,846
165,044
245,871
198,801
306,387
352,417
299,480
4,552,903
4,648,000
4,312,000
4,312,0004,648,0004,552,903299,480352,417306,387198,801245,871165,044196,84622,98233,892131,46165,323105,17696,92424,03024,6823,7946,5636,4807,84126,01025,685
       Long-term Assets Other 
0
0
81,622
66,699
74,467
16,943
0
0
0
0
2,565
2,318
2
2
9,987
9,666
8,948
9,168
-1
-1
1
2
36,000
2,000
2,00036,00021-1-19,1688,9489,6669,987222,3182,565000016,94374,46766,69981,62200
> Total Liabilities 
40,153
86,301
77,114
40,560
34,964
34,920
50,395
46,076
50,274
47,246
103,055
122,877
183,216
165,208
269,911
214,271
230,107
193,775
201,255
341,059
288,075
4,087,926
3,811,000
3,668,000
3,668,0003,811,0004,087,926288,075341,059201,255193,775230,107214,271269,911165,208183,216122,877103,05547,24650,27446,07650,39534,92034,96440,56077,11486,30140,153
   > Total Current Liabilities 
30,153
44,299
49,175
20,994
18,873
19,368
28,574
31,340
46,952
40,053
71,284
61,332
80,168
99,724
159,831
131,396
159,318
134,895
152,275
202,352
177,014
954,326
621,000
557,000
557,000621,000954,326177,014202,352152,275134,895159,318131,396159,83199,72480,16861,33271,28440,05346,95231,34028,57419,36818,87320,99449,17544,29930,153
       Short-term Debt 
0
0
0
0
0
0
0
0
3,217
2,981
20,406
5,424
16,825
17,028
25,774
11,876
37,390
81
0
14,632
13,593
455,673
182,000
147,000
147,000182,000455,67313,59314,63208137,39011,87625,77417,02816,8255,42420,4062,9813,21700000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
38,650
25,774
11,876
37,390
81
0
0
0
428,610
153,000
114,000
114,000153,000428,6100008137,39011,87625,77438,6500000000000000
       Accounts payable 
14,255
11,523
9,615
6,399
8,680
7,263
9,170
9,505
23,531
14,697
26,643
19,865
17,444
15,596
22,282
21,749
24,286
30,598
32,085
29,314
25,922
173,081
181,000
171,000
171,000181,000173,08125,92229,31432,08530,59824,28621,74922,28215,59617,44419,86526,64314,69723,5319,5059,1707,2638,6806,3999,61511,52314,255
       Other Current Liabilities 
15,898
17,296
39,560
14,595
10,193
12,105
19,404
21,835
2,211
2,744
2,451
9,095
5,172
10,651
9,512
4,414
12,698
12,761
120,190
18,489
24,697
58,842
212,000
187,000
187,000212,00058,84224,69718,489120,19012,76112,6984,4149,51210,6515,1729,0952,4512,7442,21121,83519,40412,10510,19314,59539,56017,29615,898
   > Long-term Liabilities 
0
0
27,939
19,566
16,091
15,552
21,821
14,736
3,322
7,193
31,771
61,545
103,048
65,484
110,080
82,875
70,789
58,880
48,980
138,707
111,061
3,133,600
3,190,000
3,111,000
3,111,0003,190,0003,133,600111,061138,70748,98058,88070,78982,875110,08065,484103,04861,54531,7717,1933,32214,73621,82115,55216,09119,56627,93900
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
466
399
0
61,213
48,810
2,026,821
2,043,000
0
02,043,0002,026,82148,81061,21303994660000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
1
0
2,285
0
33,735
29,192
23,791
47,248
70,323
58,481
48,980
77,494
62,251
1,106,779
1,147,000
0
01,147,0001,106,77962,25177,49448,98058,48170,32347,24823,79129,19233,73502,2850100000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
12,059
77,767
72,089
66,999
51,772
41,905
36,524
34,111
58,436
0
0
0058,43634,11136,52441,90551,77266,99972,08977,76712,0590000000000000
> Total Stockholder Equity
133,063
241,741
111,401
143,435
150,574
176,450
220,639
253,384
292,061
311,588
325,676
342,970
277,791
320,956
700,914
843,151
1,018,055
1,225,857
1,492,914
1,794,023
2,012,570
15,322,175
16,736,000
12,722,000
12,722,00016,736,00015,322,1752,012,5701,794,0231,492,9141,225,8571,018,055843,151700,914320,956277,791342,970325,676311,588292,061253,384220,639176,450150,574143,435111,401241,741133,063
   Common Stock
14,390
18,390
18,390
18,390
18,390
18,390
19,790
19,800
19,800
19,944
19,944
19,954
20,228
20,228
22,144
22,144
22,144
22,144
22,144
22,144
22,144
27,631
28,000
28,000
28,00028,00027,63122,14422,14422,14422,14422,14422,14422,14420,22820,22819,95419,94419,94419,80019,80019,79018,39018,39018,39018,39018,39014,390
   Retained Earnings Total Equity000000000000000000000000
   Accumulated Other Comprehensive Income 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
60,846
1,924
20,584
1,164,000
1,144,000
1,144,0001,164,00020,5841,92460,8460000000000000000000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
494,610
494,610
494,610
494,610
494,610
13,543,973
13,544,000
0
013,544,00013,543,973494,610494,610494,610494,610494,6100000000000000000
   Treasury Stock000000000000000000000000
   Other Stockholders Equity 
0
0
-23,492
80,361
120,248
157,983
185,727
182,405
197,091
190,181
185,116
185,254
183,348
182,138
477,972
469,929
506,569
507,177
544,864
494,610
494,610
13,543,973
13,544,000
13,543,000
13,543,00013,544,00013,543,973494,610494,610544,864507,177506,569469,929477,972182,138183,348185,254185,116190,181197,091182,405185,727157,983120,24880,361-23,49200



Balance Sheet

Currency in SEK. All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue3,512,000
Cost of Revenue-1,774,000
Gross Profit1,738,0001,738,000
 
Operating Income (+$)
Gross Profit1,738,000
Operating Expense-1,005,000
Operating Income733,000733,000
 
Operating Expense (+$)
Research Development122,000
Selling General Administrative433,000
Selling And Marketing Expenses684,000
Operating Expense1,005,0001,239,000
 
Net Interest Income (+$)
Interest Income16,000
Interest Expense-94,000
Other Finance Cost-34,000
Net Interest Income-112,000
 
Pretax Income (+$)
Operating Income733,000
Net Interest Income-112,000
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-3,712,0005,178,000
EBIT - interestExpense = 639,000
-3,712,000
-3,757,000
Interest Expense94,000
Earnings Before Interest and Taxes (EBIT)733,000-3,618,000
Earnings Before Interest and Taxes (EBITDA)1,158,000
 
After tax Income (+$)
Income Before Tax-3,712,000
Tax Provision-123,000
Net Income From Continuing Ops401,000-3,835,000
Net Income-3,851,000
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses2,779,000
Total Other Income/Expenses Net-4,445,000112,000
 

Technical Analysis of Vitrolife
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Vitrolife. The general trend of Vitrolife is BEARISH with 42.9% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Vitrolife's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-42.9%) Bearish trend (42.9%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Vitrolife AB.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 178.10 < 180.50 < 191.80.

The bearish price targets are: 157.70 > 157.00 > 155.20.

Tweet this
Vitrolife AB Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Vitrolife AB. The current mas is .

The long score for the Moving Averages is 4/14.
The longshort score for the Moving Averages is -6/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Vitrolife AB Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Vitrolife AB. The current macd is -7.24671181.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Vitrolife price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Vitrolife. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Vitrolife price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Vitrolife AB Daily Moving Average Convergence/Divergence (MACD) ChartVitrolife AB Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Vitrolife AB. The current adx is 35.44.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Vitrolife shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Vitrolife AB Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Vitrolife AB. The current sar is 181.08.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Vitrolife AB Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Vitrolife AB. The current rsi is 37.39. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Vitrolife AB Daily Relative Strength Index (RSI) ChartVitrolife AB Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Vitrolife AB. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -4/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Vitrolife price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Vitrolife AB Daily Stochastic Oscillator ChartVitrolife AB Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Vitrolife AB. The current cci is -55.91016548.

Vitrolife AB Daily Commodity Channel Index (CCI) ChartVitrolife AB Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Vitrolife AB. The current cmo is -24.10426632.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Vitrolife AB Daily Chande Momentum Oscillator (CMO) ChartVitrolife AB Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Vitrolife AB. The current willr is -75.25773196.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Vitrolife is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Vitrolife AB Daily Williams %R ChartVitrolife AB Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Vitrolife AB.

Vitrolife AB Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Vitrolife AB. The current atr is 6.80255385.

Vitrolife AB Daily Average True Range (ATR) ChartVitrolife AB Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Vitrolife AB. The current obv is 2,862,255.

Vitrolife AB Daily On-Balance Volume (OBV) ChartVitrolife AB Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Vitrolife AB. The current mfi is 20.60.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Vitrolife AB Daily Money Flow Index (MFI) ChartVitrolife AB Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Vitrolife AB.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-18STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-20STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-08STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-11BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-19WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-25CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-26CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-31MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-08MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-12ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-02-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-15WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-02-23MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-04STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-08CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-04-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-18STOCH SHORT EXITThe %K line crosses above the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-26RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-05-02STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Vitrolife AB Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Vitrolife AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5037.388
Ma 20Greater thanMa 50175.795
Ma 50Greater thanMa 100185.444
Ma 100Greater thanMa 200184.280
OpenGreater thanClose165.300
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Vitrolife with someone you think should read this too:
  • Are you bullish or bearish on Vitrolife? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Vitrolife? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Vitrolife AB

I send you an email if I find something interesting about Vitrolife AB.


Comments

How you think about this?

Leave a comment

Stay informed about Vitrolife AB.

Receive notifications about Vitrolife AB in your mailbox!